Le Lézard
Classified in: Health, Science and technology
Subject: PERSONNEL ANNOUNCEMENTS

Mike Imagawa named Managing Director, SE Asia of The Coretec Group, Inc.


TULSA, OK--(Marketwired - August 10, 2017) - The Coretec Group, Inc. (OTC PINK: CRTG) announced today that Mike Imagawa has been appointed to the position of Managing Director, Southeast Asia. In this role, Mr. Imagawa will focus on business development for energy storage and semiconductor markets in both Japan and Korea.

"I am very pleased to add Mike to the Coretec team," said Michael Kraft, The Coretec Group CEO. "The creation of this significant role was necessitated by the fact that we have been exploring, in part with Mike's valuable assistance, the development of one or more strategic partnerships in this geographical area. His experience with the energy storage and semiconductor markets is a perfect fit to advance our Coretec® HexaSilanetm technology and these relationships."

Mr. Imagawa has a demonstrated understanding of customer requirements coupled with extensive business development experience in important target markets. Prior to joining The Coretec Group, he enjoyed a distinguished career that included business development positions at GE, Umicore and Dow Corning. Mr. Imagawa holds a bachelor's degree from Kansai Gaidai University. He will remain located in Tokyo, Japan.

About The Coretec Group, Inc.
The Coretec Group, Inc. (the "Company") utilizes a portfolio of silicon-based materials to pursue commercial development in energy-focused verticals such as energy storage, solar, and solid-state lighting, as well as printable electronics and 3D displays.

For more information, visit www.thecoretecgroup.com.


These press releases may also interest you

at 13:35
Phoenix-Micron, Inc. ("Phoenix"), recognized globally for its leadership in in vivo ophthalmic imaging of small animals, today announced the MICRON Animal Stand - Pro. For the first time, inhalation anesthetic delivery is integrated into an animal...

at 13:15
Neurocrine Biosciences, Inc. , today presented the CAHtalysttm Pediatric Phase 3 clinical study baseline characteristics data for...

at 13:15
Julie Bank, chief people officer at Brighton Health Plan Solutions, has received an OnCon Icon Award for 2024. This award reflects voting by her peers that ranks her among the top 50 human resources professionals working worldwide....

at 12:46
Melmark, a nationally-recognized non-profit human services provider recently held its biennial fundraising gala, The Dream Maker's Ball: Melmark Generations. Over 200 guests gathered at the Crystal Tea Room in Philadelphia on Saturday, April 20th to...

at 12:25
The "Hematology Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering. Hematology Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the hematology...

at 12:20
Johnson & Johnson announced today results from the open-label, single-arm Phase 2 Apa-RP study evaluating adjuvant treatment with ERLEADA® (apalutamide) and androgen deprivation therapy (ADT) in patients with HRLPC who have undergone...



News published on and distributed by: